Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

There is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary...

Descripción completa

Detalles Bibliográficos
Autores: COVID Surg Collaborative, Pujol-Cano, Natalia, Segura-Sampedro, Juan José, Soldevila Verdeguer, Carla, Jerí-McFarlane, Sebastián, Gil-Catalan, Alejandro, Craus-Miguel, Andrea, Ferrer-Inaebnit, Ester, Oseira-Reigosa, Anaí, González-Argenté, Francesc Xavier
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Conselleria de Salut i Consum del Govern de les Illes Balears
Repositorio:Docusalut
Idioma:inglés
OAI Identifier:oai:docusalut.com:20.500.13003/25571
Acceso en línea:https://hdl.handle.net/20.500.13003/25571
Access Level:acceso abierto
Palabra clave:BCG Vaccine
COVID-19
Humans
SARS-CoV-2
Vaccination
Vacuna BCG
Humanos
Vacunación
Descripción
Sumario:There is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary complications and 30-day mortality.

Similares en LA Referencia